Mersana Therapeutics Inc (MRSN.OQ)
MRSN.OQ on NASDAQ Stock Exchange Global Select Market
8.02USD
19 Oct 2018
8.02USD
19 Oct 2018
Change (% chg)
$-0.29 (-3.49%)
$-0.29 (-3.49%)
Prev Close
$8.31
$8.31
Open
$8.34
$8.34
Day's High
$8.71
$8.71
Day's Low
$8.01
$8.01
Volume
15,166
15,166
Avg. Vol
50,058
50,058
52-wk High
$23.67
$23.67
52-wk Low
$7.79
$7.79
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2018 | Jun '18 | 4.19 | -0.538 |
| Mar '18 | 3.06 | -0.544 | |
| FY 2017 | Dec '17 | 3.26 | -0.613 |
| Sep '17 | 6.27 | -0.340 | |
| Jun '17 | 3.73 | -0.394 | |
| Mar '17 | 4.29 | -0.356 | |
| FY 2016 | Dec '16 | 12.00 | 0.056 |
| Sep '16 | 3.26 | -0.258 | |
| Jun '16 | 6.22 | -0.166 | |
| Mar '16 | 3.70 | -0.237 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Dec-18 | 6 | 4.48 | 6.50 | 3.00 | -- |
| Quarter Ending Mar-19 | 2 | 4.85 | 5.50 | 4.20 | -- |
| Year Ending Dec-18 | 6 | 15.77 | 18.30 | 13.00 | 20.45 |
| Year Ending Dec-19 | 6 | 20.79 | 27.00 | 16.76 | 35.45 |
| Earnings (per share) | |||||
| Quarter Ending Dec-18 | 6 | -0.62 | -0.51 | -0.73 | -0.10 |
| Quarter Ending Mar-19 | 2 | -0.55 | -0.51 | -0.59 | -- |
| Year Ending Dec-18 | 6 | -2.30 | -2.07 | -2.43 | -2.12 |
| Year Ending Dec-19 | 6 | -2.31 | -2.05 | -2.55 | -1.72 |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 85.41 | 33.64 | |
| P/E High - Last 5 Yrs. | -- | 287.36 | 45.19 | |
| P/E Low - Last 5 Yrs. | -- | 89.75 | 23.75 | |
| Beta | -- | 0.93 | 0.88 | |
| Price to Sales (TTM) | -- | 124.37 | 5.83 | |
| Price to Book (MRQ) | -- | 15.29 | 4.89 | |
| Price to Tangible Book (MRQ) | 18.86 | 14.52 | 6.51 | |
| Price to Cash Flow (TTM) | -- | 70.10 | 22.92 | |
| % Owned Institutions | 78.13 | 14.25 | 2.14 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 0.33 | 1.51 | |
| Dividend Yield - 5 Year Avg | -- | 0.24 | 1.52 | |
| Dividend 5 Year Growth Rate | -- | 2.54 | 5.40 | |
| Payout Ratio(TTM) | -- | 16.75 | 43.85 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | -- | 411.57 | 8.10 | |
| Sales (TTM) vs TTM 1 Yr. Ago | -- | 103.65 | 5.80 | |
| Sales - 5 Yr. Growth Rate | -- | 30.74 | 9.87 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | -- | 24.06 | 23.38 | |
| EPS (TTM) vs TTM 1 Yr. Ago | -- | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 37.62 | 10.92 | |
| Capital Spending - 5 Yr. Growth Rate | -- | 38.52 | 14.87 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | -- | 1.95 | 2.25 |
| Current Ratio (MRQ) | 2.53 | 5.36 | 3.05 |
| LT Debt to Equity (MRQ) | 0.00 | 34.93 | 12.76 |
| Total Debt to Equity (MRQ) | 0.00 | 36.74 | 17.18 |
| Interest Coverage (TTM) | -- | -96.75 | 37.50 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | -- | 40.09 | 54.87 | |
| Gross Margin - 5 Yr. Avg. | -- | 49.02 | 52.39 | |
| EBITD Margin (TTM) | -- | -- | -- | |
| EBITD - 5 Yr. Avg | -- | -579.09 | 11.01 | |
| Operating Margin (TTM) | -- | -786.66 | 4.07 | |
| Operating Margin - 5 Yr. Avg. | -- | -600.20 | 6.34 | |
| Pre-Tax Margin (TTM) | -- | -748.77 | 5.12 | |
| Pre-Tax Margin - 5 Yr. Avg. | -- | -605.79 | 6.78 | |
| Net Profit Margin (TTM) | -- | -749.75 | 1.39 | |
| Net Profit Margin - 5 Yr. Avg. | -- | -608.47 | 3.03 | |
| Effective Tax Rate (TTM) | -- | 23.52 | 23.24 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 18.69 | 24.16 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | -- | 22,677,535 | 808,218,600 | |
| Net Income/Employee (TTM) | -- | 1,703,754 | 95,058,584 | |
| Receivable Turnover (TTM) | -- | 20.77 | 5.78 | |
| Inventory Turnover (TTM) | -- | 2.37 | 3.63 | |
| Asset Turnover (TTM) | -- | 0.40 | 0.92 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -- | -1.39 | 10.90 | |
| Return on Assets - 5 Yr. Avg. | -- | 3.03 | 12.01 | |
| Return on Investment (TTM) | -- | 0.21 | 14.27 | |
| Return on Investment - 5 Yr. Avg. | -- | 2.10 | 15.60 | |
| Return on Equity (TTM) | -- | 1.17 | 15.99 | |
| Return on Equity - 5 Yr. Avg. | -- | 2.74 | 16.87 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | 142.99 | -- | -- |
| EPS (TTM) % | 16.61 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Mersana Therapeutics Inc
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | 6.92 | 3.23 | 64 | 58 |
| 13 Week | 42.40 | 35.47 | 85 | 61 |
| 26 Week | -- | -- | -- | 76 |
| 52 Week | -- | -- | -- | 47 |
| YTD | -- | -- | -- | 59 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 82.91% |
| # of Holders: | 85 |
| Total Shares Held: | 19,196,279 |
| 3 Mo. Net Change: | -5,916 |
| # New Positions: | 0 |
| # Closed Positions: | 2 |
| # Increased Positions: | 5 |
| # Reduced Positions: | 6 |
| # Net Buyers: | -1 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.